103 related articles for article (PubMed ID: 8620332)
1. Active oxygen species and lysophosphatidylcholine are involved in oxidized low density lipoprotein activation of smooth muscle cell DNA synthesis.
Stiko A; Regnström J; Shah PK; Cercek B; Nilsson J
Arterioscler Thromb Vasc Biol; 1996 Feb; 16(2):194-200. PubMed ID: 8620332
[TBL] [Abstract][Full Text] [Related]
2. Lysophosphatidylcholine is a major contributor to the synergistic effect of mildly oxidized low-density lipoprotein with endothelin-1 on vascular smooth muscle cell proliferation.
Watanabe T; Pakala R; Katagiri T; Benedict CR
J Cardiovasc Pharmacol; 2002 Mar; 39(3):449-59. PubMed ID: 11862125
[TBL] [Abstract][Full Text] [Related]
3. Lysophosphatidylcholine and reactive oxygen species mediate the synergistic effect of mildly oxidized LDL with serotonin on vascular smooth muscle cell proliferation.
Watanabe T; Pakala R; Koba S; Katagiri T; Benedict CR
Circulation; 2001 Mar; 103(10):1440-5. PubMed ID: 11245650
[TBL] [Abstract][Full Text] [Related]
4. Synergistic interaction between thromboxane A2 and mildly oxidized low density lipoproteins on vascular smooth muscle cell proliferation.
Koba S; Pakala R; Watanabe T; Katagiri T; Benedict CR
Prostaglandins Leukot Essent Fatty Acids; 2000 Dec; 63(6):329-35. PubMed ID: 11133169
[TBL] [Abstract][Full Text] [Related]
5. Human urotensin-II potentiates the mitogenic effect of mildly oxidized low-density lipoprotein on vascular smooth muscle cells: comparison with other vasoactive agents and hydrogen peroxide.
Watanabe T; Takahashi K; Kanome T; Hongo S; Miyazaki A; Koba S; Katagiri T; Pakara R; Benedict CR
Hypertens Res; 2006 Oct; 29(10):821-31. PubMed ID: 17283870
[TBL] [Abstract][Full Text] [Related]
6. Native and oxidized LDL enhances production of PDGF AA and the surface expression of PDGF receptors in cultured human smooth muscle cells.
Stiko-Rahm A; Hultgårdh-Nilsson A; Regnström J; Hamsten A; Nilsson J
Arterioscler Thromb; 1992 Sep; 12(9):1099-109. PubMed ID: 1326320
[TBL] [Abstract][Full Text] [Related]
7. Synergistic effect of urotensin II with mildly oxidized LDL on DNA synthesis in vascular smooth muscle cells.
Watanabe T; Pakala R; Katagiri T; Benedict CR
Circulation; 2001 Jul; 104(1):16-8. PubMed ID: 11435331
[TBL] [Abstract][Full Text] [Related]
8. Mildly oxidized low-density lipoprotein acts synergistically with angiotensin II in inducing vascular smooth muscle cell proliferation.
Watanabe T; Pakala R; Katagiri T; Benedict CR
J Hypertens; 2001 Jun; 19(6):1065-73. PubMed ID: 11403355
[TBL] [Abstract][Full Text] [Related]
9. Oxidized low density lipoprotein and lysophosphatidylcholine stimulate cell cycle entry in vascular smooth muscle cells. Evidence for release of fibroblast growth factor-2.
Chai YC; Howe PH; DiCorleto PE; Chisolm GM
J Biol Chem; 1996 Jul; 271(30):17791-7. PubMed ID: 8663300
[TBL] [Abstract][Full Text] [Related]
10. Oxidized low-density lipoprotein inhibits endothelium-dependent vasodilation by an antioxidant-sensitive, lysophosphatidylcholine-independent mechanism.
Chan H; Lougheed M; Laher I; Steinbrecher UP
J Cardiovasc Pharmacol; 2003 Jun; 41(6):856-65. PubMed ID: 12775962
[TBL] [Abstract][Full Text] [Related]
11. Antioxidants inhibit the ability of lysophosphatidylcholine to regulate proteoglycan synthesis.
Chang MY; Han CY; Wight TN; Chait A
Arterioscler Thromb Vasc Biol; 2006 Mar; 26(3):494-500. PubMed ID: 16357313
[TBL] [Abstract][Full Text] [Related]
12. The various effects of fractionated oxidized low density lipoproteins on the growth of smooth muscle cells in culture.
Lin MT; Su WC; Cheng ML; Cheng KS; Chang WC; Wing LH; Jen CJ; Wu HL
J Biomed Sci; 1999; 6(4):260-8. PubMed ID: 10420083
[TBL] [Abstract][Full Text] [Related]
13. Antioxidant N-acetylcysteine inhibits vasoactive agents-potentiated mitogenic effect of mildly oxidized LDL on vascular smooth muscle cells.
Watanabe T; Pakala R; Katagiri T; Benedict CR
Hypertens Res; 2002 Mar; 25(2):311-5. PubMed ID: 12047048
[TBL] [Abstract][Full Text] [Related]
14. Inhibition by eicosapentaenoic acid of oxidized-LDL- and lysophosphatidylcholine-induced human coronary artery smooth muscle cell production of endothelin.
Kohno M; Ohmori K; Wada Y; Kondo I; Noma T; Fujita N; Mizushige K; Mandal AK
J Vasc Res; 2001; 38(4):379-88. PubMed ID: 11455209
[TBL] [Abstract][Full Text] [Related]
15. Oxidized low-density lipoproteins potentiate the mitogenic effect of 5-hydroxytryptamine on vascular smooth muscle cells.
Watanabe T; Pakala R; Katagiri T; Benedict CR
Jpn Heart J; 2002 Jan; 43(1):35-42. PubMed ID: 12041887
[TBL] [Abstract][Full Text] [Related]
16. Enzymatically Modified Low-Density Lipoprotein Promotes Foam Cell Formation in Smooth Muscle Cells via Macropinocytosis and Enhances Receptor-Mediated Uptake of Oxidized Low-Density Lipoprotein.
Chellan B; Reardon CA; Getz GS; Hofmann Bowman MA
Arterioscler Thromb Vasc Biol; 2016 Jun; 36(6):1101-13. PubMed ID: 27079883
[TBL] [Abstract][Full Text] [Related]
17. Modulation of nonselective cation current by oxidized LDL and lysophosphatidylcholine and its inhibitory contribution to endothelial damage.
Liang GH; Park S; Kim MY; Kim JA; Choi S; Suh SH
Life Sci; 2010 May; 86(19-20):733-9. PubMed ID: 20226792
[TBL] [Abstract][Full Text] [Related]
18. Lysophosphatidylcholine: essential role in the inhibition of endothelium-dependent vasorelaxation by oxidized low density lipoprotein.
Yokoyama M; Hirata K; Miyake R; Akita H; Ishikawa Y; Fukuzaki H
Biochem Biophys Res Commun; 1990 Apr; 168(1):301-8. PubMed ID: 2328007
[TBL] [Abstract][Full Text] [Related]
19. The influence of platelet-smooth muscle cell interaction on the oxidative modification of low-density lipoprotein.
Alexander JJ; Lewis I
J Surg Res; 2002 Mar; 103(1):41-6. PubMed ID: 11855916
[TBL] [Abstract][Full Text] [Related]
20. Low- and high-density lipoproteins as mitogenic factors for vascular smooth muscle cells: individual, additive and synergistic effects.
Resink TJ; Bochkov VN; Hahn AW; Philippova MP; Bühler FR; Tkachuk VA
J Vasc Res; 1995; 32(5):328-38. PubMed ID: 7578801
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
